Elizaveta Kharitonov

Principal

Liza joined Putnam in 2025 having previously worked in Creativ-Ceutical and as an independent health economist.

Liza has over 10 years of experience in HEOR and over the years she worked on models and database studies for opioid dependence, depression, asthma, hypotension and other indications.

She has a particular interest for the modeling of infectious diseases on worked on projects for vaccines against dengue, varicella, zoster, influenza, RSV, COVID and meningococcal disease. For these projects she led the conceptualization, development and validation of dynamic, static and hybrid models, as well as the analysis of complex clinical and epidemiological data. She was responsible for the external communication of the results of these studies, including the development of multiple posters and publication, as well as the engagement with national and supranational bodies (e.g., ACIP, WHO, SAGE).

Other members.

    Louise McEntee-Richardson

    Director, Market Access
    Read bio

    Clement Francois

    Partner, HTA and Market Access Operations
    Read bio

    Grace Lee

    Consultant

    John Gordon

    Partner
    Read bio